Quantib AI Node is designed for more rapid processing of CT and MRI scans.
Artificial intelligence (AI) solutions company Quantib secured 510(k) clearance from the U.S. Food & Drug Administration (FDA) this week for its AI workflow integration platform, Quantib AI Node.
Designed to help radiologists process CT and MRI scans faster, company officials said, the “plug-and-play” tool can assist with more rapid diagnosis, potentially leading to better outcomes.
“Quick, accurate diagnoses are the first crucial step towards better outcomes, yet most of the platforms radiologist are told to work with remain underutilized because of a complicated user experience,” said Arthur Post Uiterweer, Quantib’s chief executive officer.
Company leaders said they hope securing FDA clearance will enable the platform to alleviate some pressures caused by resources that are already stretched thin due to the COVID-19 pandemic. To bring its solution closer to radiologists state-side, the Netherlands-based company has opened a New-York based office.
So far, said one investigator who has tested Quantib’s AI platform, the tool’s performance has been effective.
“Our (pre-clinical) experience with the new Quantib AI Node is excellent,” said Wouter Veldhuis, M.D., Ph.D., a radiologist with the University Medical Center Utrecht. “It integrates seamlessly and already shows it can scale with increasing load and newly available algortihms. I really see this helping us improve patient care.”
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 2nd 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
Reducing the Interval Breast Cancer Rate of Screening DBT: Can AI Have an Impact?
August 2nd 2025In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.